Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
about
Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behaviorPharmacological intervention for irritability, aggression, and self-injury in Autism Spectrum Disorders (ASD)Autism spectrum disorder in adults: diagnosis, management, and health services developmentVitamin D and Autism Spectrum Disorder: A Literature ReviewOxytocin and vasopressin: linking pituitary neuropeptides and their receptors to social neurocircuitsConsensus paper: pathological role of the cerebellum in autismNetworking in autism: leveraging genetic, biomarker and model system findings in the search for new treatmentsRole of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseasesPsychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challengesNeonatal citalopram exposure decreases serotonergic fiber density in the olfactory bulb of male but not female adult ratsAcute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strainsThe dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interactThe serotonin system in autism spectrum disorder: From biomarker to animal modelsProtocadherin α (PCDHA) as a novel susceptibility gene for autismAdvances in the research of melatonin in autism spectrum disorders: literature review and new perspectivesThe rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.Progressively increased M50 responses to repeated sounds in autism spectrum disorder with auditory hypersensitivity: a magnetoencephalographic study.Effect of maternal lipopolysaccharide administration on the development of dopaminergic receptors and transporter in the rat offspring.Reward processing in autism: a thematic series.N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autismPositive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disordersDe novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorderGene × Environment interactions in autism spectrum disorders: role of epigenetic mechanisms.Unraveling the mechanisms responsible for the comorbidity between metabolic syndrome and mental health disorders.Association of transcription factor gene LMX1B with autism.Response inhibition and serotonin in autism: a functional MRI study using acute tryptophan depletion.Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia.Are There any Relationships between Latent Toxoplasma gondii Infection, Testosterone Elevation, and Risk of Autism Spectrum Disorder?Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism.SLC6 transporters: structure, function, regulation, disease association and therapeuticsRegulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Serotonin and mental disorders: a concise review on molecular neuroimaging evidenceCoordinate regulation of mature dopaminergic axon morphology by macroautophagy and the PTEN signaling pathway.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.Decreased expression of axon-guidance receptors in the anterior cingulate cortex in autismThe 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: A PET study with [¹¹C]MDL 100907 and [¹¹C]DASB.Inverse fluoxetine effects on inhibitory brain activation in non-comorbid boys with ADHD and with ASD.NTRK2 expression levels are reduced in laser captured pyramidal neurons from the anterior cingulate cortex in males with autism spectrum disorder.
P2860
Q23913111-073D47A2-9511-410D-9446-F915CADDF1FDQ24186796-4FCD372F-F833-4370-8D4D-10AA2D1320B2Q26741443-16D1D418-D755-48BF-B345-76AECA279F6AQ26750537-909E32CF-4869-497D-A129-F62F7FAECC4FQ26781668-B0A4B9AF-B35E-4147-8EA7-2D2AD61DA2FFQ26830626-F1A9BC00-6AF3-4CEA-AE8B-8D9E605F8490Q26850307-2AE66899-2CC4-4493-943D-0B1851164455Q27024102-1194356A-C41F-44FB-8D46-0A3E0A9608F3Q27498709-9F58E43A-4A88-4350-BF11-39BDBB9F02C0Q28382837-F5EA1FDD-AE42-4AC1-A8B9-DC353AD2B267Q28384969-6AE3F327-2E49-4AE2-B8F5-002A63AC4E60Q28388719-AF51FF67-B5E5-4B18-B6F5-C6D23658DC97Q28391614-03145BAA-1EAE-4702-9D3E-8C3BE818428FQ28397228-EA92D9A8-4F52-4F3E-B196-E74BEE0A3A58Q28661706-309FDC12-6A8A-4C98-808E-D5DA6075A1DAQ30412810-FD94B285-359D-408B-B5EB-298EDA79F51FQ30434339-6039C336-FBAC-41BF-A682-1EC8C1A233AAQ30458917-99FDDFBA-5977-45D1-B949-D4B10C646510Q30462673-B1B2207F-8706-4F40-A378-42B93A2B8960Q33617477-B5EFC5D6-DC96-4516-94B9-CC574EFF15C7Q33664787-5C921F55-3AC2-4D56-ACA3-2DE8E0A176A0Q33715513-E405C482-5631-4432-8BA8-AF2EBDE86F99Q33997473-31CAB697-8BE7-4FDE-9112-50158793681BQ34000520-3CE0196B-50E9-4658-8938-DAF679E99F4AQ34013736-AA69C475-C454-4260-9333-C4124CDFEADEQ34044050-BB867683-14E8-4D8C-A085-B686FD07097FQ34073325-D1D79007-F352-4FD7-8F54-01CB667A2697Q34147502-CC41FCCB-BBA4-47BF-840F-52208FEB7A33Q34238174-2042FC1E-DE1B-4EA8-849C-08552E3091E8Q34470381-B75ED08A-DE17-491A-AE7B-0D9372A678D4Q34649517-B88DC8B0-C07B-4E09-929C-037D342E5435Q34673305-AE66C56A-D2F6-4C86-B3C6-BB7845D71138Q34942640-7A804061-118F-458F-B8AB-830BDCFAECAEQ35008868-BAD929A5-286D-48D4-895A-65BD7E93A184Q35090255-E69C951F-D598-4180-BB88-A7039008ABD7Q35150201-09D5C604-77E7-4D81-87D7-B858FE47361EQ35225592-27163AA7-89E4-4AD3-9089-436ADFF1B22FQ35577128-BA8A652A-CD94-4EB4-80C1-6AFD638A0CF1Q35607540-90B8A2CE-E2DA-408B-8A96-06BFCAC24A7CQ35633903-4CF373C8-BA61-4913-A4F1-6AA259D684FC
P2860
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
@en
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
@nl
type
label
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
@en
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
@nl
prefLabel
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
@en
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.
@nl
P2093
P50
P921
P1433
P1476
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism
@en
P2093
Etsuji Yoshikawa
Genichi Sugihara
Kazuhiko Nakamura
Masami Futatsubashi
Masatsugu Tsujii
Nori Takei
Norio Mori
Shiro Suda
Toshiro Sugiyama
Yasuhide Iwata
P356
10.1001/ARCHGENPSYCHIATRY.2009.137
P407
P577
2010-01-01T00:00:00Z